Please assess the completion status of the following clinical trial:

Trial Title: Total Intravenous Anesthesia in Sinus Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing endoscopic sinus surgery~* Advanced inflammatory sinus disease, defined as allergic fungal sinusitis, chronic rhinosinusitis with nasal polyposis, chronic rhinosinusitis with eosinophilia, or rhinosinusitis with pan-sinus opacification (Lund-Mackay score \>12).~Exclusion Criteria:~* Noninflammatory sinonasal disease~* Disease extending through the skull base or orbital wall~* American Society of Anesthesiologists Preoperative Health Status \>II~* Known non-pharmacologic coagulopathy (platelet \< 50000/mL, international normalized ratio \> 1.2)~* Preoperative anticoagulants within 7 days of surgery~* Allergy to one of the study medications~* Age under 18 years~* Non-English-speaking

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Total Intravenous (Type: EXPERIMENTAL): Intravenous propofol for maintenance of anesthesia
- Inhaled Anesthetic (Type: ACTIVE_COMPARATOR): Inhaled volatile anesthetic for maintenance of anesthesia

Based on this trial design, predict the completion outcome and termination type (if applicable).